CBO

Developments in CBO's Projections for Medicare Part D

CBO provides current information about the budgetary effects of drug provisions in the 2022 Reconciliation Act; the effects of drug price negotiation, inflation rebates, and the Medicare Part D redesign; and ongoing updates to CBO's models.

Categories -

Pages